Tuesday, 5 March 2019

FDA approves controversial ketamine-inspired nasal spray for depression

Spravato is the official name of the nasal spray containing esketamine

The FDA has just approved esketamine for adults with treatment-resistant depression, in a landmark announcement marking the first new major depression treatment introduced for clinical use in over 30 years. The nasal spray is a close chemical relative to the controversial anesthetic ketamine.

.. Continue Reading FDA approves controversial ketamine-inspired nasal spray for depression

Category: Science

Tags:

from New Atlas (Gizmag) https://ift.tt/2EQzk0l
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)